Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7203810 | 0.98 | ACE2 (0.50) | LTA4HBLMACE2GABRR1CYP1A2 | |
| SCHEMBL3693315 | 0.98 | ACE2 (0.50) | LTA4HBLMACE2GABRR1CYP1A2 | |
| SCHEMBL7897955 | 0.98 | ACE2 (0.50) | LTA4HBLMACE2GABRR1CYP1A2 | |
| SCHEMBL4653508 | 0.98 | ACE2 (0.50) | LTA4HBLMACE2GABRR1CYP1A2 | |
| SCHEMBL18791193 | 0.93 | BLM (0.52) | LTA4HBLMACE2GABRR1CYP1A2 | |
| SCHEMBL5076969 | 0.93 | BLM (0.52) | LTA4HBLMACE2GABRR1CYP1A2 | |
| SCHEMBL287670 | 0.84 | — | — | |
| SCHEMBL27747322 | 0.84 | — | — | |
| SCHEMBL28055059 | 0.83 | ACE2 (0.58) | LTA4HBLMACE2GABRR1CYP1A2 | |
| SCHEMBL7179523 | 0.83 | BLM (0.65) | LTA4HBLMACE2GABRR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101868551-B | Method for the coproduction of methyl 7-oxoheptanoate and undecylenic acid from ricinoleic acid | ARKEMA FRANCE | 2013-07-10 | — | — | CN | claimed |
| CN-101868551-A | Method for the coproduction of methyl 7-oxoheptanoate and undecylenic acid from ricinoleic acid | ARKEMA FRANCE | 2010-10-20 | — | — | CN | claimed |
| EP-0325869-B1 | NOVEL PROCESSES AND INTERMEDIATES | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-11-25 | — | — | EP | claimed |
| EP-0325869-A1 | Novel processes and intermediates | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-02 | — | — | EP | claimed |
| CN-101868551-B | Method for the coproduction of methyl 7-oxoheptanoate and undecylenic acid from ricinoleic acid | ARKEMA FRANCE | 2013-07-10 | — | — | CN | disclosed |
| CN-101868551-A | Method for the coproduction of methyl 7-oxoheptanoate and undecylenic acid from ricinoleic acid | ARKEMA FRANCE | 2010-10-20 | — | — | CN | disclosed |
| EP-0294757-B1 | Process of preparing higher order cuprate complexes | SEARLE & CO (US) | 1994-04-06 | — | — | EP | disclosed |
| US-4904820-A | Process for substituting a hydrocarbon group | G. D. SEARLE & CO. (US) | 1990-02-27 | — | — | US | disclosed |
| EP-0294757-A2 | Process of preparing higher order cuprate complexes | G.D. Searle & Co. (US) | 1988-12-14 | — | — | EP | disclosed |
| US-4777275-A | CHEMICAL INTERMEDIATE FOR PROSTAGLANDINE | G. D. SEARLE & CO. (US) | 1988-10-11 | — | — | US | disclosed |
| US-3987082-A | PROSTAGLANDIN INTERMEDIATE | MERCK & CO., INC. (US) | 1976-10-19 | — | — | US | disclosed |
| US-3950359-A | PROSTAGLANDINS AND METHODS OF MAKING SAME | MERCK & CO., INC. (US) | 1976-04-13 | — | — | US | disclosed |